Keros Therapeutics News

Keros Therapeutics | 8-K: Current report

Jun 17 17:22 ET

Keros Therapeutics | 424B5: Prospectus

Jun 17 17:20 ET

Keros Therapeutics | 8-K: Current report

Jun 17 16:06 ET

Keros Therapeutics | 8-K: Current report

Jun 17 06:20 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BIENAIME JEAN JACQUES

Jun 5 16:18 ET

Keros Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BIENAIME JEAN JACQUES

Jun 5 16:16 ET

Keros Therapeutics | 8-K: Current report

Jun 4 08:02 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GORDON CARL L

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRAY MARY ANN

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Knowles Julius

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nussbaum Ran

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kariv Tomer

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seth Alpna

Jun 3 16:19 ET

Keros Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Farzan Nima

Jun 3 16:18 ET

Keros Therapeutics | 8-K: Current report

Jun 3 08:06 ET

Keros Therapeutics | 8-K: Current report

May 30 16:04 ET

Keros Therapeutics | 8-K: Current report

May 28 22:36 ET

Keros Therapeutics | 10-Q: Quarterly report

May 8 08:08 ET

Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

May 8 08:03 ET

Keros Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 3 08:06 ET